Pericardial Diseases in Pregnancy.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
08 2023
Historique:
received: 15 12 2022
revised: 13 04 2023
accepted: 14 04 2023
medline: 14 8 2023
pubmed: 23 4 2023
entrez: 22 04 2023
Statut: ppublish

Résumé

Pericardial effusion is the most common manifestation of pericardial diseases during pregnancy. This effusion is benign, mild, or moderate, well tolerated, with spontaneous resolution after delivery; no specific treatment is required. Acute pericarditis is the second most common condition, usually requiring medical therapy during pregnancy. Cardiac tamponade and constrictive pericarditis are rare in pregnancy. Pre-pregnancy counselling is essential in women of childbearing age with recurrent pericarditis to plan pregnancy in a phase of disease quiescence and to review therapy. High-dose aspirin or nonselective nonsteroidal anti-inflammatory drugs, such as ibuprofen and indomethacin, can be used up to the 20th week of gestation. Low-dose prednisone (2.5-10 mg/d) can be administered throughout pregnancy. All of these medications, apart from high-dose aspirin, may be used during lactation. Colchicine is compatible with pregnancy and breastfeeding, and it can be continued throughout pregnancy to prevent recurrences. Appropriate follow-up with a multidisciplinary team with experience in the field is recommended throughout pregnancy to ensure good maternal and fetal outcomes.

Identifiants

pubmed: 37086835
pii: S0828-282X(23)00311-2
doi: 10.1016/j.cjca.2023.04.010
pii:
doi:

Substances chimiques

Aspirin R16CO5Y76E
Anti-Inflammatory Agents, Non-Steroidal 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1067-1077

Informations de copyright

Copyright © 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Lisa Serati (L)

Department of Internal Medicine, Fatebenefratelli Hospital, Milan, Italy. Electronic address: lisa.serati@unimi.it.

Vartan Mardigyan (V)

Department of Medicine, Jewish General Hospital, Montréal, Québec, Canada.

Costanza Caccia Dominioni (CC)

Department of Internal Medicine, Fatebenefratelli Hospital, Milan, Italy.

Francesco Agozzino (F)

Department of Internal Medicine, Fatebenefratelli Hospital, Milan, Italy.

Emanuele Bizzi (E)

Department of Internal Medicine, Fatebenefratelli Hospital, Milan, Italy.

Lucia Trotta (L)

Department of Internal Medicine, Fatebenefratelli Hospital, Milan, Italy.

Mariangela Nivuori (M)

Department of Internal Medicine, Fatebenefratelli Hospital, Milan, Italy.

Silvia Maestroni (S)

Department of Internal Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy.

Enrica Negro (E)

Department of Internal Medicine, Fatebenefratelli Hospital, Milan, Italy.

Massimo Imazio (M)

Cardiology, Cardiothoracic Department, University Hospital "Santa Maria della Misericordia," Udine, Italy.

Antonio Brucato (A)

Department of Biomedical and Clinical Sciences, University of Milan, Fatebenefratelli Hospital, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH